• National Cancer Institute
  • National Human Genome Research Institute

External Scientific Committee

The Cancer Genome Atlas (TCGA) receives advice from its External Scientific Committee (ESC), whose membership includes patient advocates, senior scientists and clinicians with relevant expertise in cancer, genomics and ethics. The members of the ESC are not principal investigators for or funded by TCGA.

Current External Scientific Committee

MemberTitleInstitutional Affiliation
Mark Chee, Ph.D.Founder, Chief Executive Officer and Chief Scientific OfficerPrognosys Biosciences, Inc., La Jolla, Calif.
Lynn Dressler, Dr.P.H.Assistant Professor and Associate Director for Policy and Ethics, Institute for Pharmacogenomics and Individualized TherapyUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, N.C.
Geoff Duyk, M.D., Ph.D.PartnerTexas Pacific Group Ventures, Menlo Park, Calif.
David E. Housman, Ph.D.Ludwig Professor of Biology; Associate in Neurology and GeneticsDavid H. Kock Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital, Boston
Chanita Hughes-Halbert, Ph.D.Associate Professor of Psychiatry and Director of the Community and Minority Cancer Control ProgramUniversity of Pennsylvania, Philadelphia
Bruce E. Johnson, M.D.Director; Associate Professor of MedicineDana-Farber Cancer Institute, Boston, Mass.; Harvard Medical School, Boston, Mass.
Susan M. Love, M.D.President and Medical DirectorDr Susan Love Research Foundation, Santa Barbara, Calif.
Jennifer A. Pietenpol, Ph.D.Director and Professor of BiochemistryVanderbilt-Ingram Cancer Center; Vanderbilt University Medical Center, Nashville, Tenn.
George W. Sledge Jr., M.D.Professor of OncologyIndiana University, Indianapolis, Ind.
Robert H. Waterston, M.D., Ph.D.Professor and ChairUniversity of Washington, Seattle

 

Past Members

MemberTitleInstitutional Affiliation
William P. Bro, B.S.President and Chief Executive OfficerKidney Cancer Association (KCA), Chicago, Ill.
Ronald A. DePinho, M.D.Professor of Medicine (Genetics)Harvard Medical School, Boston, Mass.
Sean Eddy, Ph.D.Investigator; Professor of Computational BiologyHoward Hughes Medical Institute; Washington University School of Medicine, St. Louis, Mo.
Steven Henikoff, Ph.D.InvestigatorHoward Hughes Medical Institute; Fred Hutchinson Cancer Research Center, Seattle, Wash.
Leroy Hood, M.D., Ph.D.President and DirectorInstitute for Systems Biology, Seattle, Wash.
Catherine E. Ivy, M.S.PresidentThe Ben and Catherine Ivy Foundation, Palo Alto, Calif.
Christopher J. Logothetis, M.D.Professor and Chair of Genitourinary Medical OncologyUniversity of Texas M.D. Anderson Cancer Center, Houston, Texas
Frank McCormick, Ph.D.Director and ProfessorHelen Diller Family Comprehensive Cancer Center; University of California, San Francisco, Calif.
Charles Sawyers, M.D.Marie Josée and Henry R. Kravis Chair and the Human Oncology and Pathogenesis Program ChairMemorial Sloan-Kettering Cancer Center, New York, N.Y.
Dennis J. Slamon, M.D., Ph.D.Professor and ChiefUniversity of California, Los Angeles, Calif.